v3.26.1
Cover Page - shares
12 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Document Information [Line Items]    
Document Type 20-F  
Amendment Flag false  
Document Period End Date Apr. 30, 2026  
Document Fiscal Year Focus 2026  
Document Transition Report false  
Document Shell Company Report false  
Document Fiscal Period Focus FY  
Entity Filer Category Non-accelerated Filer  
Entity Registrant Name MindWalk Holdings Corp.  
Entity Central Index Key 0001715925  
Entity File Number 001-39530  
Entity Shell Company false  
Entity Voluntary Filers No  
Current Fiscal Year End Date --04-30  
Document Accounting Standard International Financial Reporting Standards  
Entity Incorporation, State or Country Code A1  
Entity Current Reporting Status Yes  
Entity Emerging Growth Company false  
Entity Address, Address Line One Industrious 823 Congress Ave Suite 300  
Entity Address, City or Town Austin  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 78701  
Entity Address, Country US  
Entity Well-known Seasoned Issuer No  
Title of 12(b) Security Common Shares, no par value  
Trading Symbol HYFT  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding 46,711,866  
Entity Interactive Data Current Yes  
ICFR Auditor Attestation Flag false  
Document Financial Statement Error Correction [Flag] false  
Document Annual Report true  
Document Registration Statement false  
Auditor Opinion [Text Block]

Opinion on the financial statements

We have audited the accompanying consolidated statements of financial position of MindWalk Holdings Corp. (formerly known as ImmunoPrecise Antibodies Ltd.) (a British Columbia limited company) and subsidiaries (the “Company”) as of April 30, 2025 and 2024, the related consolidated statements of comprehensive loss, changes in shareholders’ equity, and cash flows for each of the three years in the period ended April 30, 2025, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of April 30, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended April 30, 2025, in conformity with Financial Reporting Standards as issued by the International Standards Board.

 
Auditor Name Davidson Grant Thornton
Auditor Firm ID 731 248
Auditor Location Vancouver, Canada Houston, Texas
Business Contact [Member]    
Document Information [Line Items]    
Contact Personnel Name R. Scott Areglado  
Entity Address, Address Line One Industrious 823 Congress Ave Suite 300  
Entity Address, City or Town Austin  
Entity Address, State or Province TX  
Contact Personnel Email Address sareglado@mindwalkai.com  
Entity Address, Postal Zip Code 78701  
Entity Address, Country US  
City Area Code 701  
Local Phone Number 404-1043